Driving Success Through Solid-State and Pre-formulation Expertise
A strong foundation in solid-state science is critical to successful small molecule drug development. With experience spanning more than 2,000 projects and 1,500+ unique drug molecules, these platforms combine data-driven insights with advanced analytical and process expertise to support solid form selection, crystallization control, and formulation readiness.
By integrating solid-state characterization, crystallization development, and preformulation strategy, these capabilities enable precise control of crystal form, physicochemical properties, and manufacturability across the development lifecycle.
